| Early intravenous beta blockade and thrombolytics in acute myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 7904119 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This article discusses therapy with beta blockade and thrombolytic agents in acute myocardial infarction. In large and well-controlled studies both treatment strategies have been shown to increase survival. Both therapies have also been demonstrated to be safe in acute myocardial infarction. Historically, the 2 different treatment strategies have been tested during different time periods, resulting in few studies with the main objective to study the combined effects of the 2 agents. From the data that are presently available, however, there is a clear suggestion of additive beneficial effect and the 2 treatments given in combination are well tolerated. |
| | |
Authors:
|
G Olsson; P Held |
Related Documents
:
|
2240919 - Selection of patients with acute myocardial infarction for thrombolytic therapy. 11075749 - Update on intravenous fibrinolytic therapy for acute myocardial infarction. 7935639 - Knowledge and practices of generalist and specialist physicians regarding drug therapy ... 3097099 - Coronary thrombolysis with recombinant tissue-type plasminogen activator: patency rate ... 7836239 - Long-term effects of thrombolytic therapy on clinical course and left ventricular funct... 8445189 - Thrombolytic therapy in review. 8729069 - Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine... 8595059 - Comparison of the cardioprotective efficacy of superoxide dismutase in a single and a r... 11231429 - Design and rationale of the arbiter trial (arterial biology for the investigation of th... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The American journal of cardiology Volume: 72 ISSN: 0002-9149 ISO Abbreviation: Am. J. Cardiol. Publication Date: 1993 Dec |
Date Detail:
|
Created Date: 1994-02-04 Completed Date: 1994-02-04 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 156G-160G Citation Subset: AIM; IM |
Affiliation:
|
Cardiovascular Medicine, Astra Hässle AB, Mölndal, Sweden. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use* Drug Therapy, Combination Fibrinolytic Agents / therapeutic use* Humans Infusions, Intravenous Myocardial Infarction / drug therapy* Survival Analysis Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Fibrinolytic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Studies on background of gamma-GTP abnormality in human multiphasic screening. (Part 3): Multiple re...
Next Document: Combined enzymatic and linkage analysis for heterozygote detection in Hunter syndrome: identificatio...